Ascendis Pharma Announces Positive Preliminary Phase 1 Data for TransCon CNP Pharmaceutical Investing
Antibe Therapeutics Announces Successful Completion of Part One of Phase 2B Dose-Ranging, Efficacy Study for ATB-346 Pharmaceutical Investing
PreveCeutical Responds to British Columbia Securities Commission Press Release Cannabis Investing News
Antares Pharma Partner Teva Announces Commercial Availability of Generic Epipen Life Science Investing
Intellipharmaceutics Submits Investigational New Drug Application to the U.S. FDA for IPCI006 (oxycodone hydrochloride immediate release) Tablets Incorporating its Abuse Deterrent and Overdose Resistant Technology Pharmaceutical Investing
